The Mayo Clinic will add 2 million square feet of research space in downtown Rochester in less than 20 years, a key piece of its Destination Medical Center (DMC) plan.
The plan, announced Tuesday by the clinic, will create an urban bioresearch campus to drive the quest for new cures as private researchers collaborate with Mayo doctors on the frontiers of medicine, said Mayo CEO John Noseworthy.
"It's a big deal," said Noseworthy, adding that there has long been a strong appetite from the private sector for such a space.
The clinic's existing footprint of 15 million square feet includes 1.3 million square feet of research space that will rise on Mayo-owned land in a six-block area of Rochester known under the Destination Medical Center plan as Discovery Square.
Noseworthy said he expects the bioresearch campus to encompass a broad array of subjects, including genomics, regenerative medicine and biotechnology.
He touted the clinic's annual research accomplishments, saying that in 2015 alone, the clinic had a $662 million research budget, started 2,723 new human-subject studies and saw Mayo research published in thousands of journal articles.
The clinic is now looking for a real estate developer to oversee the project and envisions the first groundbreaking taking place next year. No specific building plans have been presented to the city.
High stakes, big money
Mayo unveiled its plans Tuesday night at a major biotech conference, BIO, being held in San Francisco. Several people connected to the Destination Medical Center plan and Rochester are attending.